11-1226730-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002458.3(MUC5B):āc.315G>Cā(p.Glu105Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,612,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002458.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC5B | NM_002458.3 | c.315G>C | p.Glu105Asp | missense_variant | 4/49 | ENST00000529681.5 | NP_002449.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC5B | ENST00000529681.5 | c.315G>C | p.Glu105Asp | missense_variant | 4/49 | 5 | NM_002458.3 | ENSP00000436812.1 | ||
MUC5B | ENST00000525715.5 | n.373G>C | non_coding_transcript_exon_variant | 4/26 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152238Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000283 AC: 7AN: 247622Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134930
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1460410Hom.: 0 Cov.: 34 AF XY: 0.0000262 AC XY: 19AN XY: 726482
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152238Hom.: 0 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2024 | The c.315G>C (p.E105D) alteration is located in exon 4 (coding exon 4) of the MUC5B gene. This alteration results from a G to C substitution at nucleotide position 315, causing the glutamic acid (E) at amino acid position 105 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at